Hydroxychloroquine Combined With Gemcitabine in the Treatment of Advanced Non-small Cell Lung Cancer

Clinical trial NCT05647330 · UNKNOWN

Trial details

NCT number: NCT05647330
Sponsor: Henan Cancer Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hydroxychloroquine Gemcitabine Lung Neoplasms

Start date: 2022-12-15
Primary completion: 2024-10-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.